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Background and purpose: The efficacy of carotid endarterectomy (CEA) in symptomatic patients with >70% stenosis 
is accepted. The stroke risk of asymptomatic patients may not justify surgical intervention. The aim of this study is to 
use natural history data from a single unit to identify asymptomatic patients who would benefit from CEA. 
Methods: Five hundred and sixty-four patients attending for duplex ultrasound assessment of the internal carotid artery 
between 1986 and 1993 were retrospectively identified as focally asymptomatic with >40% ipsilateral stenosis. Patients 
were traced using hospital records, family practitioner databases and the Office of Population of Census and Surveys. 
The number of strokes, transient ischaemic attacks and cause of death were determined. Exclusions were 15 (2.7%) 
asymptomatic o clusions and 49 patients (8.7%) who underwent surgery for asymptomatic disease. 
Results: Thirteen patients (2.6%) were not traced, leaving 487 study patients. The average follow-up was 41 months 
(range, 1-120 months). Mean presentation age was 69 years (s.p. 8.9), and the male to female ratio was 3:2. One hundred 
and fifty-six (32%) patients died. Forty-three patients uffered strokes, of whom two had bilateral strokes. In total there 
were 16 (i/p) strokes, 25 (c/l) strokes and four strokes undetermined. The average yearly stroke rate was 2.74 per 100 
person years and the (i/p) rate 1.02 per hundred person years. There was no effect of age, sex or degree of stenosis on 
stroke. The presence of bilateral disease did increase the risk of stroke (rel risk 2.35, p = 0.029) but not ipsilateral stroke 
(rel risk 1.6, p =0.39). Patients with unilateral asymptomatic carotid disease had an all stroke rate of less than 5% in 
the fi'rst year after presentation and this was unaffected by degree of stenosis. In patients with bilateral disease the stroke 
rate in the first year after presentation increased with degree of stenosis to a stroke rate of 9.6 per 100 person years in 
patients with >90% contralateral stenosis. 
Conclusions: This data suggests that CEA will not benefit patients with unilateral asymptomatic disease. Patients with 
bilateral disease warrant inclusion in clinical trials. 
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Introduction 
Randomised controlled trials establishing carotid en- 
darterectomy (CEA) as the treatment of choice for 
patients fit for surgery with symptomatic arotid 
stenosis >70% have been available for over 5 years) '2 
Confidence in CEA as a tool for stroke prevention has 
increased and with the publication of the ACAS results 3 
many clinicians especially in the United States perform 
CEA for patients with >60% asymptomatic carotid 
disease. The rationale for this lies in the widely held 
belief that asymptomatic disease is likely to progress, 
perhaps to occlusion or to symptomatic disease. If the 
conversion of asymptomatic disease to symptomatic 
disease were frequent enough then the stroke risk of 
* Please address all correspondence to: C. D. Irvine, Department of 
Surgery, The Vascular Studies Unit, Bristol Royal Infirmary, Bristol 
BS2 8HW, U.K. 
asymptomatic carotid arterial disease would be greater 
than that of surgical intervention. There has been some 
reservation about he application of the ACAS results 
to all patients with asymptomatic carotid disease as 
the natural history data does not seem to support his 
contention. 4 In addition there is little information in 
the ACAS trial about he extent of contralateral disease 
and the number of patients with significant contra- 
lateral disease. There is no subanalysis of the effect of 
contralateral disease on stroke rate in the report of the 
ACAS findings. If the presence of bilateral disease is 
a higher risk for stroke then this omission may have 
skewed the ACAS results in favour of surgery for 
unilateral disease. 
One of the first large natural history studies was 
performed by Bock et al. ~ They studied a mixed group 
of 242 asymptomatic patients with a >70% stenosis for 
a mean follow-up of over 27 months. They found an 
annual stroke rate of 2.7% and an annual event rate 
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(stroke, TIA, and AF combined) of 6.2%. The rate of 
progression of disease was variable; often preceding 
symptoms, and contralateral disease was of equal 
importance to ipsilateral disease with respect to stroke 
risk. Other investigators studying smaller cohorts of 
patients have found similarly low stroke rates. Johnson 
et al. found an annual stroke rate of 1.7%. 6 Autret et 
al. stratified patients with respect to degree of stenosis 
and found that specific ipsilateral event rates were 
low: 0.23% for 0-50% stenosis, 2.48% for 50-75% and 
1.71% for 75-99%. 7Similarly low figures of 1.7% ipsi- 
lateral stroke rates in patients with >80% stenosis are 
reported by Mess et al. a 
Disease progression in asymptomatic patients is 
rare and symptoms often precede detection of disease 
progression. Hatsumaki et al. reported low rates of 
progression of disease (3.9%) and neurological events 
(2.9% for TIA and 0.8% for stroke) in 40 patients with 
a mean follow-up of 54 months. 9 Similar conclusions 
were reached by Naylor et al. from similar event rates. ~° 
At 10 years 86% of 219 endarterectomy patients were 
free from stroke in the non-operated hemisphere. The 
hemisphere specific stroke incidence was 1%. It is of 
concern that only one stroke had a TIA and disease 
progression was not predicted by serial colour-duplex 
scanning. 
The reporting of natural history is by no means 
uniform. Giannoni et al. in a group of 75 end- 
arterectomy patients but with a smaller degree of 
stenosis (15-45%) and shorter follow-up (mean 21 
months) reported an event rate of 33% and a stroke 
rate of 5.3%. 1~ He concluded " . . .  the basic trend in 
the follow-up of patients with bilateral carotid artery 
disease, is that the contralateral lesion may evolve and 
become symptomatic.' These symptoms are generally 
TIAs but five patients (5.3%) suffered strokes related 
to the unoperated side, all without warning TIAs." 
Prior to the publication of the ACAS results ran- 
domised trials had proved inconclusive. The CA- 
SANOVA group found no benefit from surgery but 
randomisation i this study did not include asympto- 
matic patients with a >90% stenosis - these patients 
received surgery. 12 The Mayo Clinic group stopped re- 
cruiting after they experienced high rates of post- 
operative myocardial infarction in the group 
randomised to surgery. 13 Hobson et al. reporting from 
the Veterans Affairs Hospitals 14 demonstrated a benefit 
from surgery but the outcome of unoperated asympto- 
matic patients (controls) with severe stenoses (76-90%) 
was much better than had been demonstrated by other 
larger multicentre trials. This finding and other sub- 
group anomalies coupled with reservations about the 
classification of neurological events prompted Barnett 15 
to question the reliability of the results from this small 
study. 
The aim of this study was to identify asymptomatic 
patients who might benefit from surgery by utilising 
the natural history data of a large group of patients 
with asymptomatic carotid disease presenting to a 
single unit between 1986 and 1993. 
Methods 
The records of all patients undergoing carotid duplex 
scanning at the Bristol Royal Infirmary Vascular Stud- 
ies Unit for any indication between 1 January 1986 
and 31 December 1993 were examined. The Vascular 
Studies Unit performs between 700 and 900 carotid 
duplex scans per year and over 6000 records were 
studied. Scans were performed by two investigators 
in total but >80% of scans were performed by a single 
investigator. Over the time period three different du- 
plex machines were used, ATL® Mk600, UM9, and 
HDI. Frequency changes in the internal carotid artery 
blood flow were recorded. Degree of stenosis was 
determined using standard tables. 14 Patients were iden- 
tified as having significant disease >40% stenosis of 
the internal carotid artery. This figure was chosen as 
being the lowest degree of stenosis at which all patients 
would have been noted in the reports to have a flow 
disturbance. If patients had significant disease they 
were further stratified into unilateral and bilateral 
disease and whether the disease was symptomatic or 
asymptomatic. In keeping with other studie& 2symp- 
tomatic arotid arterial disease was taken to be disease 
that corresponded to ipsilateral symptoms: either TIA 
- episodes of temporary and focal cerebral dysfunction 
of vascular origin, rapid in onset, and of variable 
duration, Amaurosis Fugas (AF) - transient ischaemia 
of the retina leading to temporary loss of part of the 
visual field, or non-disabling stroke. Asymptomatic 
carotid arterial disease was taken to be all other disease 
>40%. 
A cohort of 564 patients with asymptomatic disease 
was identified. The presenting symptoms, extent of 
disease, degree of disease and whether asymptomatic 
CEA was performed was noted. The patients' general 
practitioner was contacted by mail. The clinical status 
of the patient with respect o survival, cerebral isch- 
aemic symptoms and address of the patient were 
determined. Patients were then contacted irectly and 
asked to either fill in a questionnaire (see Fig. 1) 
relating to their symptoms from the follow-up period 
or return for neurological examination and duplex 
scanning. Any non-responders were re-mailed. Any 
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~Title~> ~t'h-stNam~ ~astNam~ ~Eb~ 
((Addrmsl}) ((Addr~2~ ((Ch'~) <<PostalCode~ 
I will be able to attend for reseanning. Transport equired 
Please circle. If you are attending, please do not complete the questionnaire 
If you are tmable to attend, please colnplete Ibis questionnaire: 
Car otid Artery DDeaxe Quc.qtionnair e
1. Have you had any of the following symptoms: (please ring as appropriate) 
(a) Stroke No / Yes r 
If YES please fillin the date ...J.._J....., and side(s) Le~ / Right / Both sides 
(b) Any temporary numbness or w~cness No / Yes 
If YES please fill in date ....J......Z......, and side(s) Left/Right/Both sides 
(e) Blindness: No / Yes. If YES, please give date....../.....Z....., side: L / R/L+R 
(d) Disturbed Vision: No I Yes. If YES please give date ...J....J.... and side L / R/L+R 
(e) Headaches, dizzy spells or blackouts: No / yes 
2. What medication are you on at pleseat? 
Aspirin Yes / No Please List ~y  others: 
3. Have you been troubled by any of the fonow/~ 
Heart Attack 
High Blood Pressure 
Diabetes 
AtOm 
Poor cia~lafion i  the legs No/Yes. 
No/Y~..IfYE~when ............. / ........... J ......... 
No/Y~. 
No/Y~.IfYES, docontmlwi~/~blets / insu l in  
No/Yes. 
Thank you for completing this questionnaire. 
Fig. 1. Patient questionnaire to determine symptoms and ability to attend for repeat duplex scanning. 
patients with equivocal responses on questionnaire 
were re-mailed with a questionnaire 17 for the detection 
of TIA, previously validated and with a sensitivity of 
87% and a specificity of 75%. Patients without a general 
practitioner on the hospital database were traced via 
the Family Health Services Association. Any patients 
that could not be traced in this manner were then 
traced via the Office of Population Census and Surveys. 
Data relating to patient survival, cause of death, 
cerebral symptoms, progression of disease and in- 
tervening CEA was collated. Cause of death was de- 
termined from death certificate, hospital records, and 
general practitioner records. If a cause of death could 
not be obtained then the patient was deemed un- 
traceable. The general practitioners of patients who 
were traced from death certificate data were contacted 
to ascertain any cerebral ischaemic events prior to 
death. 
Data analysis included the production of descriptive 
statistics, Kaplan-Meier plots and Cox proportional 
hazard models; all were carried out in the SPSS® 
statistical software package. Kaplan-Meier plots ob- 
tained for each factor of interest were examined to 
ascertain possible predictors of stroke and survival, 
but also to examine the assumptions necessary to hold 
for Cox Proportional Hazard model. These models 
enable us to analyse time-to-event data, examining 
several factors of interest at the same time and hence 
adjusting for their effects on each other. Relative risks 
of stroke and survival are generated from these risk 
models. Comparison of cohort ages was with the 
Mann-Whitney U-test carried out on the Unistat® 
statistical package. Fisher's exact text (SPSS®) was 
used to assess significance of the frequency of fatal 
stroke. 
Results 
Five hundred and sixty-four patients attending for 
duplex ultrasound assessment of the internal carotid 
artery between 1986 and 1993 were retrospectively 
identified as focally asymptomatic with >40% ip- 
silateral stenosis. Thirteen patients (2.6%) were not 
traced. Disease was stratified into groups on the basis 
Eur J Vasc Endovasc Surg Vol 16, September 1998 
248 C.D. Irvine et al. 
Tab le  1. Demography  o f  pat ient  cohor t  by  year .  
Year Mean age (S.D.) >40 >70 >90 % with 
bilat disease 
All patients 
1993 69.5 (9.1) 27 39 19 51 
1992 69.0 (9.0) 31 45 28 45 
1991 68.5 (9.9) 28 34 22 68 
1990 72.0 (8.2) 20 31 24 49 
1989 67.0 (8.8) 23 24 12 53 
1988 67.5 (7.2) 18 14 13 63 
1987 66.7 (7.5) 23 25 11 47 
1986 65.0 (8.6) 22 18 13 49 
69 (8.1) 192 230 142 
Exclusions 
Operated 68.1 (8.6) 3 24 22 68 
Occlusions 71.3 (7.9) - - 15 86 
Untraced 70.7 (8.0) 5 5 3 62 
Study cohort 69 (8.0) 184 201 102 
of the degree of stenosis: between 40 and 70% (>40%), 
between 70 and 90% (>70%), between 90 and 99% 
(>90%), and occluded. The demography on a yearly 
basis is shown in Table 1. Exclusions were 15 asympto- 
matic occlusions (2.6%) and 49 patients (5.4%) who 
underwent immediate surgery (within 3 months of 
presentation) for asymptomatic disease (bilateral CEA 
for asymptomatic disease in two cases). This left 487 
patients for follow-up. Mean follow-up of the 487 
patients who had not undergone surgery for asympto- 
matic disease was 41 years (range, 1-120 months). 
Mean presentation age was 69 years (S.D. 8.9), and the 
overall male to female ratio was 3:2. The demography 
of the 49 patients who underwent surgery for asympto- 
matic disease and hence were excluded is shown in 
Table 1. Comparison with patients who did not un- 
dergo surgery reveals no difference between these two 
groups with respect o sex, age (Mann-Whitney U) or 
presence of bilateral disease. There were three patients 
with a 60% asymptomatic stenosis who underwent 
surgery. There were a high number of patients (20) 
with a >90% asymptomatic stenosis who underwent 
surgery. The ratio of >90% disease to disease between 
70% and 90% in the non-operated group was 3:5 and 
in the operated group it was approximately 1:1. The 
presence of contralateral symptomatic disease and the 
number of contralateral CEAs were similar between 
non-operated and operated groups. The percentage of
patients undergoing CEA for asymptomatic disease 
was similar in all year cohorts (mean 14%, range 
7-19%). The percentage of patients with symptomatic 
contralateral disease at presentation was also similar 
in all year cohorts (mean 44%, range 34-56%), of whom 
57% underwent contralateral CEA. Follow-up of patients 
undergoing CEA for asymptomatic disease was not 
Tab le  2. Cause  o f  death .  
Cause of death Number (%) 
Cardiovascular 79 (50) 
Stroke 23 (15) 
Carcinoma 30 (19) 
Respiratory 6 (4) 
Trauma 2 (1) 
Other 16 (11) 
Total 156 100 
1 
0 .9  
0.8 
0.7 
0.6 
0.5 
0.4 
0.3 
0.2 
0.1 
I , I , I , I ~ I t i ~ I E I 
0 10 20 30 40 50 60 70 80 
Survival time (months) 
Fig. 2. Effect of bilateral disease on cumulative survival. ( - - - )  
Unilateral; ( - - )  bilateral. 
performed routinely. However, local hospital records 
have demonstrated that two of these patients ex- 
perienced perioperative strokes, one of which was fatal. 
Survival 
One hundred and fifty-six patients died over the study 
period (Table 2). The commonest cause of death was 
cardiovascular. Of the fatal strokes ix were ipsilateral, 
14 contralateral nd two were indeterminate. The pro- 
portion of fatal strokes in each category of stroke was 
not significantly different: 6/16 (37%) ipsilateral, 14/ 
25 (58%) contralateral and 2/4 (50%) indeterminate 
(Fisher's exact test, p = 0.498). Kaplan-Meier plots for 
survival indicated that Cox Proportional Hazard mod- 
els would be appropriate. When fitted alone in the 
model neither sex nor stenosis had a significant effect 
on survival (p = 0.148 and p = 0.432 respectively). The 
relative risk of dying if male is 1.27 compared to 
female sex (95% confidence interval (CI), 0.92-1.77). 
The relative risk of stenosis >70% compared to <70% 
is 1.27 (95% CI, 0.88-1.82). A similar result is obtained 
by comparing >90% disease with <90% disease (rel 
risk 1.16, 95% CI, 0.76-1.77). 
Age and bilateral disease were both found to have 
a significant effect on survival (p=0.012 and 0.026 
respectively) (Fig. 2). When included in the model 
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Tab le  3. E f fect  o f  t ime on  al l  s t roke  and  ips i la te ra l  s t roke  ad jus ted  
(per  100 pat ient  years ) .  
Year of follow-up 
1st 2nd 3rd 4th 5th 6th 7th 
year year year year year year year 
All strokes (no.) 23 6 5 4 3 1 1 
I/p strokes (no.) 4 4 4 1 2 0 1 
Person years (py) 439 372 277 191 114 74 54 
Rate, all strokes 5.24 1.61 1.81 2.09 2.64 1.36 1.86 
(no./py) 
Ratei/p strokes 0.91 1.08 1.45 0.52 1.76 0 1.86 
(no./py) 
together, hence adjusting one for another, both remain 
significant (age p = 0.008, bilateral disease p= 0.026). A 
patient over the age of 80 has a relative risk of 1.82 
compared to a patient of less than 80 years (95% CI, 
1.17-2.84). The relative risk for a patient with bilateral 
disease is 1.5 compared to unilateral disease (95% CI, 
1.05-2.14). 
TIA or amaurosis fugax 
Only seven patients returned equivocal initial ques- 
tionnaires. These patients were all mailed with the 
validated questionnaire 17 and none were symptomatic 
using this instrument. Twenty-eight patients uffered 
non-stroke vents (TIA, AF). In five patients the side 
of the symptoms was undefined. Two patients had 
bilateral symptoms. There were 10 (i/p) events and 
11 (c/l) events. Two patients with i /p  symptoms went 
on to occlusion without stroke. Three patients under- 
went CEA after the development of symptoms. There 
was no increase in the number of events with length 
of follow-up. The data source for TIA and AF in those 
patients who died was general practitioner ecords 
alone. 
Strokes 
Forty-three patients suffered strokes; two had both 
ipsilateral ( i /p) and contralateral (c/l) strokes. There 
were 16 (i/p) strokes, 25 (c/l) strokes and four strokes 
undetermined. The average yearly all stroke rate was 
2.74 per hundred person years (range, 1.3-5.2) and the 
average yearly ipsilateral rate was 1.02 per hundred 
person years (range, 0-2.3). There was considerable 
yearly variation in stroke rates between different years 
of follow-up, because of this a rate calculated from all 
years after presentation would produce a misleading 
overall rate per annum. Due to this effect event rates 
are given for each year of follow-up separately (Table 
3). They are calculated as the number of events that 
i I  
0.9 
0.8 
0.7 
0.6 
0 .5 -  
0 .4 -  
0.3 i 
0 
I , I ~ r , I r I , I , I , r 
10 20 30 40 50 60 70 80 
Survival (months) 
Fig.  3. Effect of degree of stenosis on cumulative survival. (A )  
40-70%; (D) 70-90%; (C)) >90%. 
25 
20 
15 
Z I0  
1 2 3 4 5 6 7 
Year of follow-up 
Fig. 4. Number of stroke vents per year of follow-up. 
occur during a particular year of follow-up, divided 
by the total number of person years followed in that 
year after presentation. The number of events and 
person years decrease with increasing year after pre- 
sentation and the precision of the data in the later 
years of follow-up decreases because of this. All strokes 
were most likely to occur in the first year after pre- 
sentation (Fig. 4 and Table 3). There appears to be no 
real effect of time on ipsilateral strokes (Table 3), and 
the risk of ipsilateral stroke would seem to be a 
relatively constant phenomena. Cox proportional haz- 
ard model examined the effect of recognised risk fac- 
tors. The relative risk and 95% confidence limits of 
these factors with respect o stroke is shown in Fig. 5. 
There is no effect for age, sex, or degree of stenosis. 
Bilateral disease, however, significantly increases the 
risk of all strokes (rel risk 2.35, p=0.029, 95% CI, 
0.49-3.15), but the effect is mainly due to the increased 
risk of contralateral stroke (rel risk 3.92, p = 0.026, 95% 
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All strokes 
Age (> 80 Years) 
Female 
> 70% 
> 90% 
Bilat. Dis.* 
Ipsilatera] strokes 
Age 
Female 
> 70% 
> 90% 
Bilat. Dis.* 
Contralateral strokes 
Age 
Female 
> 70% 
> 90% 
Bilat. Dis.* 
@ 
¢ 
@ 
¢ 
,A  
iw 
¢ 
0 ] I I ] I I ] /y I 
0 1.0 2.0 3.0 4.0 5.0 6.0 7.0 13 
Fig. 5. Relative risk for the effect of recognised risk factors on stroke (* p<0.05). (O) Relative risk; (--) 95% CI. 
CI, 1.17-13.11)i As 30% of all patients had contralateral 
symptomatic disease the predictive value of bilateral 
disease relates mainly to this. 
Stratification of these yearly rates with respect o 
the degree of stenosis (40-70%, 70-90%, >90%) led to 
difficulties due to small numbers in some subgroups 
and no events. First year follow-up was used because 
the number of person years and events were greatest 
in this year. Later years of follow-up had too few 
events to generate meaningful data. The all stroke rate 
for the first year of follow-up was higher for all degrees 
of stenosis when bilateral disease was present. How- 
ever, Cox Proportional Hazard models indicated that 
an interaction between degree of stenosis and bilateral 
disease is not significant (p=0.322). Unilateral 
asymptomatic disease had an all stroke of less than 
five per hundred person years for all groups. The 
rate of ipsilateral stroke was low, between 0-1.7 per 
hundred person years but no patients with >90% 
disease experienced an ipsilateral stroke in this first 
year following presentation. 
Duplex follow-up 
One hundred and seventy-three patients were able to 
attend for follow-up duplex scanning; 36% of the total. 
These 173 patients are, however, 52% of those patients 
who could attend, 156 patients having died in the 
study period. All patients were taking aspirin or dy- 
piridamole (two patients). Average length of follow- 
up among these 173 was 45 months (range 2-120). 
One hundred and twelve patients did not exhibit 
ipsilateral disease progression. The effect of length of 
follow-up on ipsilateral disease progression is shown 
in Fig. 6. The percentage ofpatients who exhibit disease 
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Fig. 6. Disease progression with time. (,) >40%; (n) >70%; (A) 
>90%. 
progression i creases with time. Twenty-three patients 
developed symptoms; 31% of all patients developing 
symptoms in the study. Ten patients progressed with 
symptoms. Symptoms were ipsilateral to disease pro- 
gression in only six patients. Symptoms in this group 
were two strokes and five TIAs; one patient ex- 
periencing a TIA prior to a stroke. The four patients 
with contralateral symptoms experienced one stroke 
and four TIAs; one patient experiencing a TIA prior to 
a stroke. Eleven patients developed symp[oms without 
ipsilateral disease progression. Symptoms were six 
contralateral TIAs, two contralateral strokes, two ip- 
silateral TIAs and one ipsilateral stroke. The patient 
with an ipsilateral stroke was demonstrated to have a 
haemorrhagic event on computed tomography. 
Discussion 
For surgery in asymptomatic carotid artery disease to 
be of benefit o the patient, the annual risk of stroke 
for conservatively managed asymptomatic disease 
must be greater than the risk of subsequent stroke 
combined with the perioperative risk of stroke and 
death in the operated group. In Great Britain and 
the U.S.A., despite best medical treatment including 
control of hypertension, diabetes, stopping smoking 
and antiplatelet therapy, 200 strokes occur per 100 000 
population per annum. Previous work has suggested 
that asymptomatic patients with carotid artery disease 
experience an annual ipsilateral stroke rate of about 
1-2% per annum; ranging from <1% to 3%. 3-7 The 
morbidity and mortality from carotid endarterectomy 
in symptomatic patients varies between 0-6% and may 
be less in an asymptomatic group) It is clear from 
these figures that the risk of ipsilateral stroke from 
carotid disease is not uniform and neither are surgical 
results. 
The application of these results to the management 
of a general population with asymptomatic disease 
depends on the reliability of the data collected and 
the subpopulation studied. In this study the mean age 
of presentation, the male to female ratio and vascular 
risk factors are similar to others. The reliability of 
symptom reporting and cause of death is also per- 
tinent. It is well recognised that up to 50% of TIAs may 
not be reported. 2°Stroke is a rather more catastrophic 
medical event and thus more likely to appear in general 
practitioner records. Self-reporting and the use of ques- 
tionnaires as employed in this study is, however, the 
most sensitive method of detecting symptoms. R° Only 
13 (2.5%) patients were not traced. Two hundred and 
twenty-seven (73% patients who were traceable and 
alive) responded to a questionnaire. Of these 173 
patients, 36% of the total and 53% of those patients 
who were alive, attended for rescanning and were 
also questioned irectly about symptoms. Only two 
patients volunteered new symptoms when questioned 
directly, but these were not TIAs or AF (one patient 
with carpal tunnel syndrome and one with pulsatile 
tinnitus). The symptoms of 87 patients (18%) were 
available from the general practitioner alone. The cause 
of death was obtained from hospital records, general 
practitioner records or death certificates. Patients were 
regarded as not traced if a cause of death could not 
be determined. The low rate of untraced patients 
demonstrates that the cause of death could be obtained 
in nearly all patients. The reliability of death cer- 
tification is, however, always a cause for concern. Only 
8% of the patients traced by hospital records had 
undergone post-mortem examination. There is there- 
fore a risk of under-reporting of cerebral events in this 
study, although the data for CVA are considered more 
reliable than for TIAs. 
The subpopulation studied is one referred for in- 
vestigation of cerebral symptoms. While elderly 
patients may not be referred for investigation and the 
population may thus be biased these patients are also 
unlikely to be surgical candidates. The population 
studied is, however, biased by the practice of per- 
forming carotid endarterectomy on a selective basis. 
The number of patients undergoing endarterectomy 
for asymptomatic disease was less than 10%. The 
demography ofthese patients is, however, very similar 
to those that were not operated. The differences were 
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Table 4. Effect of degree of stenosis on all strokes and ipsilateral strokes in the first year after 
presentation. 
Degree of All strokes (/hundred person years) Ipsilateral strokes (/hundred person 
stenosis years) 
Total Unilat Bilat Total Unilat Bilat 
C/1 side C/1 side 
All Asym Symp All Asym Syrup 
40-70 4.2 1.7 5.7 0 9.1 0.6 0 0.6 0 1.5 
7040 6.3 4.5 7.4 5.4 7.0 1.7 1.5 1.8 5.4 0 
>90% 5.1 4.0 9.6 0 6.8 0 
0 = no events in this subgroup. 
that only three patients with asymptomatic disease 
less than 70% underwent surgical intervention and the 
ratio of >70% disease to >90% disease in the operated 
group was higher than in the non-operated group. 
The presence of bilateral disease, which was the one 
risk factor that predicted stroke, was not different 
between the two groups. 
The effect of stratification of patients into "at risk" 
groups may help to identify any patient groups that 
have higher stroke and/or event rates who might 
benefit from surgical intervention. It might be pos- 
tulated that asymptomatic patients with tight stenoses 
of >70% are likely to have a higher stroke risk than 
patients with less severe degrees of stenosis in the 
same way that symptomatic patients do. In addition 
it is not yet clear whether management should be 
influenced by the clinical circumstances in which the 
asymptomatic stenosis is discovered. For example, is 
the stroke risk greater if the contralateral internal 
carotid is diseased? Other uncertainties include the 
risks associated with a stenosis and ipsilateral isch- 
aemic event separated by more than 6 months in time 
and the influence of sex on survival. 
The overall survival of patients was not dependent 
upon the degree of stenosis or sex. Survival was de- 
creased by the presence of old age and bilateral disease. 
It should be noted, however, that the main cause of 
death was cardiovascular nd not stroke. This parallels 
the findings of the Framingham study which suggested 
that asymptomatic carotid disease was just a marker 
for generalised atherosclerosis. 
Our goal in the surgical treatment of asymptomatic 
carotid isease must be to identify clinically applicable 
risk factors that would allow stratification of patients 
into an "at risk" group benefiting from surgery. Our 
attempt o produce these groups for all strokes has 
been successful. The data from the first year of follow- 
up quite clearly shows that patients both with symp- 
tomatic or asymptomatic contralateral disease have 
stroke rates >5% p.a., the highest rate being 9.6% p.a. 
for all patients with bilateral disease and a >90% 
stenosis. Patients with >70% or >90% disease had 
higher all stroke rates than those patients with 40-70% 
disease. The picture for ipsilateral strokes is not nearly 
so clear partly because there were fewer ipsilateral 
strokes. Table 3 shows that ipsilateral event rates were 
remarkably constant over time at approximately 1% 
p.a. (1 event per 100 person years in each year of 
follow-up). Stratification of the 16 ipsilateral strokes 
by degree of stenosis and the presence or absence of 
contralateral disease produces mall subgroups with 
statistically unreliable stroke rates. The data from the 
first year of follow-up in Table 4 is typical. It is unclear 
whether stratification of ipsilateral stroke by degree 
of stenosis or the presence of bilateral disease will 
produce the "at risk" groups that we seek. The low 
but constant rate of ipsilateral strokes would tend to 
suggest not. 
Duplex follow-up was available for over 50% of 
patients who were alive at the time of recall. The 
total number of patients exhibiting disease progression 
increased with follow-up. The rate of disease pro- 
gression was, however, constant over time. Only 51 
of 173 patients showed disease progression over a 
mean follow-up period of 45 months. Twenty-three 
of the follow-up patients developed symptoms. This 
group represented a third of all patients developing 
symptoms in the study and this group of patients have 
a projected 5-year event rate of 16.6%. This 5-year 
event rate is similar to the 12.3% of the study group 
as a whole. This suggests that the group attending for 
duplex scanning is similar in terms of event risk to 
the groups as a whole. Ten patients progressed with 
symptoms but symptoms were ipsilateral in only six. 
There were two strokes, one preceded by a TIA. There 
were also 11 patients who exhibited symptoms without 
ipsilateral disease progression. The only patient with 
an ipsilateral stroke experienced a haemorrhagic event 
on computed tomography. This duplex follow-up data 
suggests that the percentage of patients under- 
going disease progression is relatively constant up to 
5 years follow-up and that disease progression does 
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not predict stroke. These results confirm the findings 
of Naylor et aI. I° and lend weight to the contention 
that ad hoc surveillance of asymptomatic disease is 
unrewarding. 
In summary, patients with unilateral asymptomatic 
disease have an annual stroke rate of less than 1% 
indicating that surgical intervention will be of little or 
no benefit. Duplex follow-up of asymptomatic patients 
to assess troke risk on the basis of disease progression 
is unrewarding. Patients with bilateral disease may 
benefit from inclusion in major multicentre trials to 
assess the efficacy of surgical intervention and we 
would urge the co-ordinators of the European ACST, 
and any other subsequent trial, to analyse the results 
for bilateral disease separately from unilateral disease. 
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